ABOSAcumen Pharmaceuticals, Inc.

ABOS Stock Price, Valuation & Chart | Acumen Pharmaceuticals, Inc.

Compare

$3.100+0.18 (+6.16%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ABOS intrinsic value ABOS calculated fair value vs price

Overview Financials Dividends Ratios

ABOS Historical price chart

ABOS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization223.91M

PE Ratio-1.9

EPS-1.63

Trading Volume247.28K

Today's High/Low3.12/2.93

Dividend Yield0.00

52 Week High/Low3.6/1.21

Shares Outstanding72.23M

ABOS Financial Statement

ABOS Analyst ratings

ABOS Analysis & performance metrics

ABOS Company profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on…

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in…

ABOS Management team

Name

Position

Alex Braun M.B.A.

Vice President & Head of Investor Relations

Kelly Carranza

Vice President, Finance & Accounting and Corporate Controller

Caleb E. Finch Ph.D.

Co-Founder

Matt ZugaCFO

Chief Financial Officer & Chief Business Officer

Daniel J. O'Connell M.B.A.CEO

Chief Executive Officer & Director

Derek M. Meisner Esq., J.D.

Chief Legal Officer & Corporate Secretary

William L. Klein Ph.D.

Co-Founder

James Doherty Ph.D.

President & Chief Development Officer

Name

Position

Alex Braun M.B.A.

Vice President & Head of Investor Relations

Kelly Carranza

Vice President, Finance & Accounting and Corporate Controller

Caleb E. Finch Ph.D.

Co-Founder

Matt ZugaCFO

Chief Financial Officer & Chief Business Officer

Daniel J. O'Connell M.B.A.CEO

Chief Executive Officer & Director

Derek M. Meisner Esq., J.D.

Chief Legal Officer & Corporate Secretary

William L. Klein Ph.D.

Co-Founder

James Doherty Ph.D.

President & Chief Development Officer

Management Team

Alex Braun M.B.A.

Vice President & Head of Investor Relations

Kelly Carranza

Vice President, Finance & Accounting and Corporate Controller

Caleb E. Finch Ph.D.

Co-Founder

Matt ZugaCFO

Chief Financial Officer & Chief Business Officer

Daniel J. O'Connell M.B.A.CEO

Chief Executive Officer & Director

Derek M. Meisner Esq., J.D.

Chief Legal Officer & Corporate Secretary

William L. Klein Ph.D.

Co-Founder

James Doherty Ph.D.

President & Chief Development Officer

Management

Alex Braun M.B.A.

Vice President & Head of Investor Relations

Kelly Carranza

Vice President, Finance & Accounting and Corporate Controller

Caleb E. Finch Ph.D.

Co-Founder

Matt ZugaCFO

Chief Financial Officer & Chief Business Officer

Daniel J. O'Connell M.B.A.CEO

Chief Executive Officer & Director

Derek M. Meisner Esq., J.D.

Chief Legal Officer & Corporate Secretary

William L. Klein Ph.D.

Co-Founder

James Doherty Ph.D.

President & Chief Development Officer

Total 8 executives

ABOS Frequently asked questions

What is Acumen Pharmaceuticals, Inc. (ABOS) Stock Price?

Current stock price of Acumen Pharmaceuticals, Inc. (ABOS) stock is $3.100. The stock price is +6.16% higher in the session. The intraday range can be seen from this page. Volume of Acumen Pharmaceuticals, Inc. (ABOS) stock is 247.28K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Acumen Pharmaceuticals, Inc. (ABOS) stock price going up or down today?

The stock price of Acumen Pharmaceuticals, Inc. (ABOS) can change with earnings, company news, and overall market sentiment. Acumen Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Acumen Pharmaceuticals, Inc. stock expensive at its current price?

Whether Acumen Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABOS on this page is -1.90. EPS on this page is -1.63. Compare those figures with peers and growth expectations before deciding if the current Acumen Pharmaceuticals, Inc. price is justified.

How has the stock price of Acumen Pharmaceuticals, Inc. (ABOS) performed historically?

Historical performance for Acumen Pharmaceuticals, Inc. (ABOS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABOS reacted to past earnings and market events.

Should I buy Acumen Pharmaceuticals, Inc. (ABOS) stock, at this price?

Buying Acumen Pharmaceuticals, Inc. (ABOS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.